8:01 am La Jolla Pharm announces final dosing in Phase 2 clinical trial of GCS-100 in chronic kidney disease
View todays social media effects on LJPC
View the latest stocks trending across Twitter. Click to view dashboard
See who La is hiring next, click here to view
